Zobrazeno 1 - 1
of 1
pro vyhledávání: '"2019nCoV-302 Study Group"'
Autor:
Heath, Paul T, Galiza, Eva P, Baxter, David N, Boffito, Marta, Browne, Duncan, Burns, Fiona, Chadwick, David R, Clark, Rebecca, Cosgrove, Catherine, Galloway, James, Goodman, Anna L, Heer, Amardeep, Higham, Andrew, Iyengar, Shalini, Jamal, Arham, Jeanes, Christopher, Kalra, Philip A, Kyriakidou, Christina, McAuley, Daniel F, Meyrick, Agnieszka, Minassian, Angela M, Minton, Jane, Moore, Patrick, Munsoor, Imrozia, Nicholls, Helen, Osanlou, Orod, Packham, Jonathan, Pretswell, Carol H, San Francisco Ramos, Alberto, Saralaya, Dinesh, Sheridan, Ray P, Smith, Richard, Soiza, Roy L, Swift, Pauline A, Thomson, Emma C, Turner, Jeremy, Viljoen, Marianne E, Albert, Gary, Cho, Iksung, Dubovsky, Filip, Glenn, Greg, Rivers, Joy, Robertson, Andreana, Smith, Kathy, Toback, Seth, 2019nCoV-302 Study Group
Publikováno v:
2019nCoV-302 Study Group 2021, ' Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine ', New England Journal of Medicine, vol. 385, no. 13, pp. 1172-1183 . https://doi.org/10.1056/NEJMoa2107659
The New England Journal of Medicine
The New England Journal of Medicine
BACKGROUND: Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that contains the full-length spike glycoprotein of the prototy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247e32870579fce0287503bfa7c66a08
https://pure.qub.ac.uk/en/publications/0fd8bb54-0aba-472d-99d0-551f739ab5c9
https://pure.qub.ac.uk/en/publications/0fd8bb54-0aba-472d-99d0-551f739ab5c9